The MHC-specific enhanceosome and its role in MHC class I and β2-microglobulin gene transactivation

被引:75
作者
Gobin, SJP
van Zutphen, M
Westerheide, SD
Boss, JM
van den Elsen, PJ
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands
[2] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
关键词
D O I
10.4049/jimmunol.167.9.5175
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The promoter regions of MHC class I and beta (2)-microglobulin (beta (2)m) genes posses a regulatory module consisting of S, X, and Y boxes, which is shared by MHC class II and its accessory genes. In this study we show that, similar to MHC class II, the SXY module in MHC class I and beta (2)m promoters is cooperatively bound by a multiprotein complex containing regulatory factor X, CREB/activating transcription factor, and nuclear factor Y. Together with the coactivator class II transactivator this multiprotein complex drives transactivation of these genes. In contrast to MHC class II, the multiprotein complex has an additional function in the constitutive transactivation of MHC class I and beta (2)m genes. The requirement for all transcription factors in the complex and correct spacing of the binding sites within the SXY regulatory module for complex formation and functioning of this multiprotein complex strongly suggests that this complex can be regarded as a bona fide enhanceosome. The general coactivators CREB binding protein, p300, general control nonderepressible-5, and p300/CREB binding protein-associated factor exert an ancillary function in MHC class I and beta (2)m transactivation, but exclusively through the class II transactivator component of this enhanceosome. Thus, the SXY module is the basis for a specific enhanceosome important for the constitutive and inducible transactivation of MHC class I and beta (2)m genes.
引用
收藏
页码:5175 / 5184
页数:10
相关论文
共 40 条
[1]   HLA CLASS-I ALLELE (HLA-A2) EXPRESSION DEFECT ASSOCIATED WITH A MUTATION IN ITS ENHANCER-B INVERTED CAT BOX IN 2 FAMILIES [J].
BALAS, A ;
GARCIASANCHEZ, F ;
GOMEZREINO, F ;
VICARIO, JL .
HUMAN IMMUNOLOGY, 1994, 41 (01) :69-73
[2]   The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element [J].
Brown, JA ;
Rogers, EM ;
Boss, JM .
NUCLEIC ACIDS RESEARCH, 1998, 26 (18) :4128-4136
[3]   The enhanceosome and transcriptional synergy [J].
Carey, M .
CELL, 1998, 92 (01) :5-8
[4]   The bare lymphocyte syndrome: Molecular clues to the transcriptional regulation of major histocompatibility complex class II genes [J].
DeSandro, A ;
Nagarajan, UM ;
Boss, JM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (02) :279-286
[5]   Associations and interactions between bare lymphocyte syndrome factors [J].
DeSandro, AM ;
Nagarajan, UM ;
Boss, JM .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (17) :6587-6599
[6]   Assembly of functional regulatory complexes on MHC class II promoters in vivo [J].
Fontes, JD ;
JabraneFerrat, N ;
Peterlin, BM .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 270 (03) :336-345
[7]   The class II trans-activator CIITA interacts with the TBP-associated factor TAF(II)32 [J].
Fontes, JD ;
Jiang, B ;
Peterlin, BM .
NUCLEIC ACIDS RESEARCH, 1997, 25 (12) :2522-2528
[8]  
Fontes JD, 1999, MOL CELL BIOL, V19, P941
[9]  
Gobin SJP, 1998, J IMMUNOL, V161, P2276
[10]   Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: The ISRE-mediated route and a novel pathway involving CIITA [J].
Gobin, SJP ;
Peijnenburg, A ;
Keijsers, V ;
vandenElsen, PJ .
IMMUNITY, 1997, 6 (05) :601-611